Overview

Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This study is to investigate the efficacy and safety of M516102 and to evaluate the dose response relationship of M516102 and placebo, in the treatment of pruritus associated with atopic dermatitis.
Phase:
Phase 2
Details
Lead Sponsor:
Maruho Co., Ltd.